NASDAQ: NAGENiagen Bioscience Inc Stock Ownership - Who owns Niagen Bioscience?
Insider buying vs selling
Have Niagen Bioscience Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ozan Pamir | Chief Financial Officer | 2025-11-14 | 4,464 | $6.81 | $30.40kBuy |
| Ozan Pamir | Chief Financial Officer | 2025-11-14 | 2,220 | $6.85 | $15.21kBuy |
| Robert N. Fried | Chief Executive Officer | 2025-04-09 | 66,667 | $3.30 | $220.00kBuy |
| Carlos Luis Lopez | SVP General Counsel | 2025-03-07 | 273 | $7.86 | $2.15kBuy |
| Frank L. Jaksch Jr. | Director | 2024-12-13 | 50,001 | $3.66 | $183.00kBuy |
| Frank L. Jaksch Jr. | Director | 2024-12-13 | 37,161 | $6.19 | $229.95kSell |
NAGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NAGE insiders and whales buy or sell their stock.
NAGE Shareholders
What type of owners hold Niagen Bioscience Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Hoi Shuen Solina Holly Chau | 32.17% | 25,672,139 | $164.30M | Insider |
| Barry C. Honig | 26.49% | 21,143,044 | $135.32M | Insider |
| Champion River Ventures Ltd | 24.25% | 19,349,652 | $123.84M | Insider |
| Michael Brauser | 19.07% | 15,219,914 | $97.41M | Insider |
| Frank L. Jaksch Jr. | 17.87% | 14,260,386 | $91.27M | Insider |
| Phillip Md Et Al Frost | 15.79% | 12,602,939 | $80.66M | Insider |
| Tricia A. Jaksch | 7.80% | 6,225,155 | $39.84M | Insider |
| Sheep Flp Black | 7.80% | 6,225,155 | $39.84M | Insider |
| Margie Chassman | 5.52% | 4,408,640 | $28.22M | Insider |
| Vanguard Group Inc | 5.04% | 4,021,650 | $25.74M | Institution |
NAGE vs Biotech Stocks
Niagen Bioscience Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.